Crossmark

Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant <i>Escherichia coli</i>

Crossref DOI link: https://doi.org/10.1039/c8ra01854e

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Balasubramaniyan, Sakthivel https://orcid.org/0000-0003-1066-9878
Irfan, Navabshan https://orcid.org/0000-0003-4630-5259
Umamaheswari, Appavoo https://orcid.org/0000-0002-0896-1530
Puratchikody, Ayarivan https://orcid.org/0000-0002-6235-2728
License Information

Version of Record valid from 2018-06-29
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Sakthivel Balasubramaniyan (ORCID)

: Navabshan Irfan (ORCID)

: Navabshan Irfan (ResearcherID)

: Appavoo Umamaheswari (ORCID)

: Ayarivan Puratchikody (ORCID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 2 March 2018; Accepted 21 June 2018; Version of Record published 29 June 2018